Noticias y vídeos - BIOPHARMX CORP.

BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020 PR Newswire CAMPBELL, Calif., May 15, 2020 CAMPBELL, Calif. , May 15, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX" or the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today announced that, in anticipation of closing its merger with Timber Pharmaceuticals, it will effect a 1-for-12 reverse stock...

...

BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting PR Newswire CAMPBELL, Calif., May 13, 2020 CAMPBELL, Calif. , May 13, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") today announced that all proposals related to its proposed merger with Timber Pharmaceuticals LLC ("Timber") were approved by BioPharmX's stockholders at a special meeting held on May 13, 2020 . The proposed merger remains subject to further customary closing...

...

BioPharmX Corporation Urges Stockholders to Vote Now on Proposed Merger with Timber Pharmaceuticals PR Newswire CAMPBELL, Calif., May 8, 2020 CAMPBELL, Calif., May 8, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") is urging its stockholders to vote now on the proposed merger of BioPharmX with Timber Pharmaceuticals LLC ("Timber") and related matters as described in the proxy statement/prospectus. "We encourage all of our stockholders to review the proxy statement...

...

BioPharmX Corporation Announces that its Special Stockholders' Meeting will now be held on Wednesday, May 13, 2020 at 10:00 AM eastern time Special Stockholders' Meeting will now be a virtual meeting PR Newswire CAMPBELL, Calif., April 27, 2020 CAMPBELL, Calif. , April 27, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") today announced that the date of its special stockholders' meeting to consider and vote on the proposed merger of BioPharmX with Timber...

BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain Trading PR Newswire CAMPBELL, Calif., March 25, 2020 CAMPBELL, Calif. , March 25, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) (the "Company"), a specialty pharmaceutical company focused on developing innovative medical dermatology products, received notification on March 24, 2020 from the NYSE American LLC (the "NYSE American" or "Exchange") that the NYSE American has determined it will commence...

...

...

...

BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement PR Newswire SAN JOSE, Calif. and WOODCLIFF LAKE, N.J., Jan. 28, 2020 SAN JOSE, Calif. and WOODCLIFF LAKE, N.J. , Jan. 28, 2020 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX) ("BioPharmX") and Timber Pharmaceuticals LLC ("Timber"), a privately held biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that they have entered...

...

...

...

...

...

BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate Update PR Newswire SAN JOSE, Calif., Dec. 10, 2019 SAN JOSE, Calif. , Dec. 10, 2019 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company focused on developing innovative medical dermatology products, today reports financial results for the fiscal quarter ended October 31, 2019 . Corporate Update In the third quarter, we retained Locust Walk Partners, LLC, a global life...

...

...